Current through Register Vol. XLI, No. 44, November 1, 2024
Section 64-52-4 - Circumstances Under Which PertussisVaccine Should Not Be Administered4.1. Pertussis vaccine should not be administered to an individual who is less than six weeks of age or who is seven or more years old, except that in epidemic situations, immunization may be started as early as two weeks of age, and the first three doses can be given as frequently as four weeks apart.4.2. If pertussis vaccine is to be administered to an individual who is less than six weeks of age and the seventh birthday, general use guidelines (a recommended immunization schedule based on data collected by the Advisory Committee on Immunization Practices of the United States Public Health Service and the Committee on Infectious Diseases of the American Academy of Pediatrics) provided by the department to local and county health departments should be consulted.4.3. Pertussis vaccine should not be administered to an individual who has an evolving neurologic disorder.4.4. When an infant or child returns for a second or later dose of pertussis vaccine, the parent should be questioned about any adverse events occurring after the previous dose.4.5. Pertussis Vaccine Contradictions -- Major adverse reactions following pertussis immunization that constitute absolute contraindications to further administration of pertussis vaccine are as follows: (a) collapse or shock occurring within forty-eight hours;(b) crying persisting for three or more hours or an unusual high-pitched cry occurring within forty-eight hours;(c) temperature of 104.9 degrees fahrenheit or greater occurring within forty-eight hours;(d) a convulsion or seizure with or without accompanying fever occurring up to three days after receipt of pertussis vaccine;(e) severe alteration of consciousness within seven days;(f) generalized and/or focal neurologic signs within seven days;(g) systemic (severe) allergic reactions within seven days;(h) excessive somnolence within seven days;(i) an evolving neurologic disorder within seven days; or(j) an episode of limpness and paleness within seven days. If additional circumstances under which pertussis vaccine should not be administered become known by the scientific community, the department will review the above list to determine whether amendment is warranted. Nothing in this section relieves a health care provider from responsibility for reporting all adverse reactions as required under Section 8.1 (c).
4.6. Pertussis vaccine should not be administered if the individual has had confirmed Bordetella pertussis infection.4.7. Pertussis vaccine should not be administered if the individual is hypersensitive to the vaccine components.4.8. The administration of pertussis vaccine to an individual is not required if, in the written, signed opinion of the health care provider, the risk to the potential recipient outweighs the benefits both to the potential recipient and to the public.